SCHEMBL31408448

SCHEMBL31408448

CC(=O)NCc1cc2cc(Cl)c(-c3cnc(C)c(F)c3)cc2[nH]1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ BDKRB1 P46663 7/20 0.35
▸ MTNR1A P48039 4/20 0.34
▸ MTNR1B P49286 4/20 0.34
▸ MAPT P10636 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ ABL1 P00519 1/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ HTT P42858 1/20 0.32
▸ PDK1 Q15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31408594 0.91 SMN1; SMN2 (0.38) RAB9ANPC1SMN1; SMN2BDKRB1MTNR1A
SCHEMBL31408442 0.88 SMN1; SMN2 (0.36) RAB9ANPC1SMN1; SMN2BDKRB1MTNR1A
SCHEMBL31408473 0.88 SMN1; SMN2 (0.37) RAB9ANPC1SMN1; SMN2MTNR1AMTNR1B
SCHEMBL31408333 0.87 SMN1; SMN2 (0.40) SMN1; SMN2MTNR1AMTNR1BMAPT
SCHEMBL31408351 0.86 SMN1; SMN2 (0.40) RAB9ANPC1SMN1; SMN2MTNR1AMTNR1B
SCHEMBL31408611 0.85 SMN1; SMN2 (0.41) RAB9ANPC1SMN1; SMN2MTNR1AMTNR1B
SCHEMBL31408461 0.81 SMN1; SMN2 (0.43) SMN1; SMN2MTNR1AMTNR1BMAPTKDM4E
SCHEMBL31408362 0.81 METTL3 (0.44) SMN1; SMN2
SCHEMBL31408238 0.80 SMN1; SMN2 (0.40) SMN1; SMN2MTNR1AMTNR1BMAPTKDM4E
SCHEMBL31408267 0.80 SMN1; SMN2 (0.40) RAB9ANPC1SMN1; SMN2MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049604-A1 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2025-03-06 — — WO disclosed
Send feedback